Search results
The No-Brainer Buys: 3 Stocks That Are Absolute Must-Owns Right Now
InvestorPlace via Yahoo Finance· 7 days agoToday, we discuss three must-own stocks as major Wall Street indices reach new highs. The rise in...
Why many lung cancer patients who have never smoked have worse outcomes
Science Daily· 1 day agoThe study, published in Nature Communications, shows that lung cancer cells with two particular genetic mutations are more likely to double their genome, which helps them to withstand treatment ...
Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma
MedPage Today· 4 days agoImmunotherapy may have been given too late, researchers suggested
Surviving to Thriving: Enhancing QoL in Breast Cancer
Medscape· 10 hours agoThe growing number of breast cancer survivors highlights the need for holistic and coordinated...
Making Tough Decisions: A Candid Discussion Between Oncs
Medscape· 1 day agoDrs Mark Lewis and Don Dizon discuss what keeps them up at night.
Mutation Mystery Solved: Why Lung Cancer Treatments Often Fail in Non-Smokers
SciTechDaily· 1 day agoConducted by researchers from UCL, the Francis Crick Institute, and AstraZeneca, the study is...
Why many people with lung cancer who have never smoked don't respond well to treatments
MedicalNewsToday via AOL· 1 day agoResearchers have honed in on two genetic mutations they say may be responsible for the...
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
Yahoo Finance· 4 days agoMost bosses are defeating shareholder attempts so far this year to tamp down their pay. The question...
Oncologists Voice Financial Concerns of Genomic Testing
Medscape· 1 day agoDr Maurie Markman discusses genomic testing and the associated financial considerations.
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 1 day agoRivals Face Off With Regeneron Stock The companies are far from alone in the burgeoning COPD...